Amedisys Alpha and Beta Analysis
| AMEDDelisted Stock | USD 100.99 0.03 0.03% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Amedisys. It also helps investors analyze the systematic and unsystematic risks associated with investing in Amedisys over a specified time horizon. Remember, high Amedisys' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Amedisys' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Amedisys |
Amedisys Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Amedisys market risk premium is the additional return an investor will receive from holding Amedisys long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Amedisys. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Amedisys' performance over market.| α | 0.00 | β | 0.00 |
Amedisys Fundamentals Vs Peers
Comparing Amedisys' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Amedisys' direct or indirect competition across all of the common fundamentals between Amedisys and the related equities. This way, we can detect undervalued stocks with similar characteristics as Amedisys or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Amedisys' fundamental indicators could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Amedisys to competition |
| Fundamentals | Amedisys | Peer Average |
| Return On Equity | 0.0667 | -0.31 |
| Return On Asset | 0.0652 | -0.14 |
| Profit Margin | 0.04 % | (1.27) % |
| Operating Margin | 0.12 % | (5.51) % |
| Current Valuation | 3.43 B | 16.62 B |
| Shares Outstanding | 32.89 M | 571.82 M |
| Shares Owned By Insiders | 1.95 % | 10.09 % |
Amedisys Opportunities
Amedisys Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Amedisys Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Amedisys or other delisted stocks. Alpha measures the amount that position in Amedisys has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Amedisys Upcoming Company Events
As portrayed in its financial statements, the presentation of Amedisys' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amedisys' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Amedisys' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Amedisys. Please utilize our Beneish M Score to check the likelihood of Amedisys' management manipulating its earnings.
| 21st of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Amedisys
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Amedisys Stock
If you are still planning to invest in Amedisys check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amedisys' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges |